DE3574707D1 - Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. - Google Patents

Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Info

Publication number
DE3574707D1
DE3574707D1 DE8585115802T DE3574707T DE3574707D1 DE 3574707 D1 DE3574707 D1 DE 3574707D1 DE 8585115802 T DE8585115802 T DE 8585115802T DE 3574707 T DE3574707 T DE 3574707T DE 3574707 D1 DE3574707 D1 DE 3574707D1
Authority
DE
Germany
Prior art keywords
arabinofuranoside
monophosphate
conjugates
beta
adenin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585115802T
Other languages
English (en)
Inventor
Luigi Fiume
Corrado Busi
Alessandro Mattioli
Massimo Baldacci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratori Baldacci SpA
Original Assignee
Laboratori Baldacci SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Baldacci SpA filed Critical Laboratori Baldacci SpA
Application granted granted Critical
Publication of DE3574707D1 publication Critical patent/DE3574707D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DE8585115802T 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. Expired - Fee Related DE3574707D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23998/84A IT1177381B (it) 1984-12-11 1984-12-11 Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive

Publications (1)

Publication Number Publication Date
DE3574707D1 true DE3574707D1 (de) 1990-01-18

Family

ID=11211397

Family Applications (2)

Application Number Title Priority Date Filing Date
DE198585115802T Pending DE184838T1 (de) 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE8585115802T Expired - Fee Related DE3574707D1 (de) 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE198585115802T Pending DE184838T1 (de) 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Country Status (9)

Country Link
US (1) US4794170A (de)
EP (1) EP0184838B1 (de)
JP (1) JPH0633320B2 (de)
AT (1) ATE48612T1 (de)
AU (1) AU576923B2 (de)
CA (1) CA1252719A (de)
DE (2) DE184838T1 (de)
ES (1) ES8704945A1 (de)
IT (1) IT1177381B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1207507B (it) * 1985-10-21 1989-05-25 Baldacci Lab Spa Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
IT1245217B (it) * 1991-03-12 1994-09-13 Baldacci Lab Spa Coniugato di azidotimidina ed albumina umana procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT1256110B (it) * 1992-11-23 1995-11-28 Procedimento di coniugazione di nucleosidi antivirali con albumina umana lattosaminata
ITMI20010027A1 (it) * 2001-01-10 2002-07-10 Uni Di Bologna Dipartimento Di Composizioni teraputiche per una chemioterapia locoregionale non invasiva delle micrometastasi epatiche
ATE411819T1 (de) * 2003-02-17 2008-11-15 Upperton Ltd Konjugate für medizinische abbildungen umfassend träger, targeting-anteile und kontrastmittel

Also Published As

Publication number Publication date
CA1252719A (en) 1989-04-18
AU5118685A (en) 1986-06-19
ATE48612T1 (de) 1989-12-15
ES8704945A1 (es) 1987-05-01
AU576923B2 (en) 1988-09-08
ES549828A0 (es) 1987-05-01
IT1177381B (it) 1987-08-26
IT8423998A1 (it) 1986-06-11
EP0184838B1 (de) 1989-12-13
IT8423998A0 (it) 1984-12-11
JPS61171430A (ja) 1986-08-02
EP0184838A3 (en) 1987-04-29
EP0184838A2 (de) 1986-06-18
US4794170A (en) 1988-12-27
DE184838T1 (de) 1987-03-19
JPH0633320B2 (ja) 1994-05-02

Similar Documents

Publication Publication Date Title
HUT60512A (en) Process for producing polyethylene glycol conjugates of proteins
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
IL83684A0 (en) Arylcarboxylic acid derivatives,their preparation and their use as fungicides
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
FI102836B1 (fi) Menetelmä glykosaminoglykaanilla muunnetun proteiinin valmistamiseksi
EP0243012A3 (en) Pyridyl-acrylic acid ester derivatives, process for their preparation and their use as fungicides
NO891415L (no) Fremstilling av substituerte flavonoidforbindelser og salter og farmasoeytiske preparater derav.
DE3688031T2 (de) Galenische formen des verapamils, deren herstellung sowie diese enthaltende arzneimittel.
ES2169429T3 (es) Glicoconjugados de derivados modificados de la camptotecina (enlace en 20-o).
DE3574707D1 (de) Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
FI891718A (fi) Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer.
DE3776620D1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.
ATE149507T1 (de) Lösliche, nichttoxische derivate von basischen polyenmakroliden, ihre herstellung und verwendung
ES2164050T3 (es) Preparacion de compuestos de interleuquina-6.
OA09794A (fr) Dérivés de pyridone amino acide azetidinyl substitués, leur préparation et leur application en tant que médicaments.
PT84130A (fr) Procede de preparation de nouveaux derives de 3-alkoxyflavones et de leurs compositions therapeutiques
ATE112276T1 (de) Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ATE60778T1 (de) Oligosaccharide, verfahren zu ihrer herstellung und ihre anwendung.
OA09419A (fr) Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation.
DE3680857D1 (de) Reaktionsverbindung von 9-(2-hydroxyethoxymethyl)-guanin mit lactosaminiertem menschlichem albumin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
IL82409A0 (en) Nicotinic acid derivatives,their preparation and their use as fungicides
FR2617164B1 (fr) Nouveaux derives de la decahydroquinoleine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
HUT54039A (en) Process for producing galenic compositions ensuring optimal biological accessibility of 2-hydroxy-5-methyllaurophenoneoxime active ingredient
SE9002508L (sv) Asymmetrisk syntes av furo(3,4-c)-pyridinderivat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: BARZ, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 80803 MUENCHEN

8339 Ceased/non-payment of the annual fee